NCT05254678

Brief Summary

The primary purpose of this study is to determine the feasibility of our proposed intervention approach involving (1) an integrated physiotherapy and exercise intervention for individuals with breast cancer who are undergoing chemotherapy and (2) delivery of programming via an electronic health (eHealth) application. The secondary objective is to determine the efficacy of the program on upper extremity outcomes, general physical fitness, cancer treatment-related symptoms and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 24, 2022

Completed
1.6 years until next milestone

Study Start

First participant enrolled

September 20, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 6, 2024

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

February 5, 2026

Status Verified

February 1, 2026

Enrollment Period

5 months

First QC Date

February 14, 2022

Last Update Submit

February 2, 2026

Conditions

Keywords

exercisephysical therapyeHealth

Outcome Measures

Primary Outcomes (1)

  • Completion rate

    Defined as \>70% participants completing at least 70% of exercise sessions and the post-study assessment

    10 weeks

Secondary Outcomes (20)

  • Recruitment rate

    one year

  • Attendance rate

    10 weeks

  • Program Satisfaction

    10 weeks

  • Symptoms

    10 weeks

  • Health-related Quality of Life

    10 weeks

  • +15 more secondary outcomes

Other Outcomes (2)

  • Grip strength (optional)

    10 weeks

  • Core muscular endurance (optional)

    10 weeks

Study Arms (2)

Standard exercise program

ACTIVE COMPARATOR

Participants in this group will take part the general exercise program delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group exercise sessions (connection via zoom platform embedded in HEAL-ME), (2) independent exercise workouts within the application, and (3) exercise specific education within the Education Module of the HEAL-ME application.

Behavioral: general exercise

Integrated physiotherapy and exercise

EXPERIMENTAL

Participants in this group will take part in an integrated physiotherapy and exercise intervention delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group physiotherapeutic exercise sessions (connection via zoom platform embedded in HEAL-ME), (2) independent physiotherapeutic exercise workouts, and (3) breast cancer specific physiotherapy education delivered through weekly modules.

Behavioral: general exercise

Interventions

A 10-week integrated physiotherapy and general exercise intervention compared to a general exercise intervention alone.

Also known as: physiotherapy
Integrated physiotherapy and exerciseStandard exercise program

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult females with a diagnosis of breast cancer (Stage Ic-III);
  • be able to participate in mild levels of activity at minimum;
  • have completed cancer surgery involving a mastectomy or breast conserving surgery involving either an axillary lymph node dissection or sentinel lymph node biopsy;
  • having completed or undergoing adjuvant chemotherapy +/- biological therapy treatment (eligible from 4 weeks to one year post-surgery at baseline);
  • speak and understand English.

You may not qualify if:

  • unable to commit to the 10-week virtual program including testing sessions at the Cancer Rehabilitation clinic in the Corbett Hall at the University of Alberta;
  • do not have regular access to the internet and a smart device or computer in the home.
  • are scheduled to undergo neoadjuvant chemotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta/ Cross Cancer Institute

Edmonton, Alberta, T6G 2G4, Canada

Location

MeSH Terms

Conditions

Breast NeoplasmsMotor Activity

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesBehavior

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Officials

  • Margaret McNeely

    University of Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Independent assessors will be used for collection of objective outcomes. The independent assessors will be blinded to group allocation.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized controlled feasibility trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2022

First Posted

February 24, 2022

Study Start

September 20, 2023

Primary Completion

February 6, 2024

Study Completion

December 30, 2024

Last Updated

February 5, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

On completion of the trial, data will be available through the University of Alberta\'s Dataserve

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
When study findings have been published
Access Criteria
The data on repository will be available on request to the principal investigator.

Locations